<unk>  binds to both the activated coagulation factor IX and to factor X, mediating the activation of the latter. This is normally the function of coagulation factor VIII, which is missing in haemophilia A patients.
Emicizumab
Brolucizumab
Satralizumab
Theralizumab
Natalizumab
Caplacizumab
Etaracizumab
Ixekizumab